Abstract
Levels of glutathione (GSH) in tumour tissue may be important in determining the clinical response to certain anticancer agents. Recent reports have suggested that D,L-buthionine-S,R-sulphoximine (BSO), a specific inhibitor of GSH synthesis, may be used to deplete tumour cell GSH and thus increase the therapeutic ratio of these agents. We have previously shown that 1-naphthol is a potential antitumour agent, and that its possible metabolite 1,4-naphthoquinone is thiol reactive and capable of redox cycling. It was therefore of interest to investigate the effect of pretreatment with BSO, on the toxicity of these agents, to tumour cells. For comparison we included three other cytotoxic agents, melphalan, helenalin and menadione, the toxicities of which are reported to be modulated by intracellular GSH. Depletion of GSH using BSO did not effect the toxicity of 1-naphthol, or 1,4-NQ but did produce slight potentiation of the cytotoxicities of menadione, helanalin and melphalan. The lack of effect of BSO on 1-naphthol and 1,4-NQ is not easily explained but if one also considers the modest potentiation of cytotoxicity+ achieved with the other agents studied, the potential use of BSO in combined chemotherapy is at best rather modest.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Jordan, J., d'Arcy Doherty, M. & Cohen, G. Effects of glutathione depletion on the cytotoxicity of agents toward a human colonic tumour cell line. Br J Cancer 55, 627–631 (1987). https://doi.org/10.1038/bjc.1987.127
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.127
This article is cited by
-
Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine
Scientific Reports (2016)
-
Changes in plasma thiol levels induced by different phases of treatment in breast cancer; the role of commercial extract from black chokeberry
Molecular and Cellular Biochemistry (2013)
-
Non-myelotoxic antitumour effects ofl-dopa, buthionine sulphoximine and tamoxifen on neuroblastoma cells in vitro and in vivo
Journal of Cancer Research and Clinical Oncology (1991)
-
Relationship between glutathione levels and drug or radiation sensitivities in human gastric cancer cell lines in vitro
Investigational New Drugs (1991)
-
Sensitization of human melanoma cells to melphalan cytotoxicity by Adriamycin and carmustine
Journal of Cancer Research and Clinical Oncology (1991)